| Predicted Trait | |
| Reported Trait | Glaucoma | 
| Mapped Trait(s) | glaucoma (MONDO_0005041) | 
| Score Construction | |
| PGS Name | MTAG_glaucoma | 
| Development Method | |
| Name | Clumping and Thresholding (C+T) | 
| Parameters | r2 = 0.1; p < 0.001 | 
| Variants | |
| Original Genome Build | NR | 
| Number of Variants | 2,673 | 
| Effect Weight Type | NR | 
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000066 | 
| Citation (link to publication) | Craig JE et al. Nat Genet (2020) | 
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 351,696 individuals (100%) | 
| Score Development/Training | European: 100% 8,004 individuals (100%) | 
| PGS Evaluation | |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | 
|---|---|---|---|
| GWAS Catalog: GCST009722 Europe PMC: 31959993 | 351,696 individuals | European | NR | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| — | [ 
 | European | ANZRAG | Advanced glaucoma | — | — | — | Used to select the optimal p-value threshold. Adjusted for sex and first four PCs | 
| — | [, 
 47.0 % Male samples | European | NR | Advanced glaucoma | Mean = 59.0 years Sd = 10.16 years | — | — | Used to replicate OR seen in ANZRAG on UK cases from Southhampton and Liverpool | 
| PGS Performance Metric ID (PPM) | PGS Sample Set ID (PSS) | Performance Source | Trait | PGS Effect Sizes (per SD change) | Classification Metrics | Other Metrics | Covariates Included in the Model | PGS Performance: Other Relevant Information | 
|---|---|---|---|---|---|---|---|---|
| PPM000422 | PSS000245| European Ancestry| 1,795 individuals | PGP000066 | Craig JE et al. Nat Genet (2020) | Reported Trait: Primary open-angle glaucoma (POAG) | — | AUROC: 0.8 | — | age, sex, self-reported family history | — | 
| PPM000426 | PSS000249| South Asian Ancestry| 7,033 individuals | PGP000066 | Craig JE et al. Nat Genet (2020) | Reported Trait: Glaucoma | — | AUROC: 0.76 [0.73, 0.79] | — | age, sex | Model 3 | 
| PPM000424 | PSS000248| European Ancestry| 3,112 individuals | PGP000066 | Craig JE et al. Nat Genet (2020) | Reported Trait: Glaucoma | — | AUROC: 0.75 [0.73, 0.76] | — | age, sex | Model 3 | 
| PPM000429 | PSS000247| European Ancestry| 3,112 individuals | PGP000066 | Craig JE et al. Nat Genet (2020) | Reported Trait: Primary open-angle glaucoma (POAG) | — | AUROC: 0.76 [0.72, 0.81] | — | age, sex | Model 3 | 
| PPM000425 | PSS000249| South Asian Ancestry| 7,033 individuals | PGP000066 | Craig JE et al. Nat Genet (2020) | Reported Trait: Glaucoma | — | AUROC: 0.64 [0.59, 0.68] | — | — | Model 1 | 
| PPM000423 | PSS000248| European Ancestry| 3,112 individuals | PGP000066 | Craig JE et al. Nat Genet (2020) | Reported Trait: Glaucoma | — | AUROC: 0.66 [0.64, 0.68] | — | — | Model 1 | 
| PPM000428 | PSS000247| European Ancestry| 3,112 individuals | PGP000066 | Craig JE et al. Nat Genet (2020) | Reported Trait: Primary open-angle glaucoma (POAG) | — | AUROC: 0.67 [0.63, 0.72] | — | — | Model 1 | 
| PPM000427 | PSS000246| European Ancestry| 965 individuals | PGP000066 | Craig JE et al. Nat Genet (2020) | Reported Trait: Glaucoma in MYOC p.Gln368Ter carriers | — | — | HR (Hazard Ratio; highest vs. lowest tertile of PRS): 3.4 [1.7, 6.6] | sex, PCs 1-6 | — | 
| PPM000421 | PSS000245| European Ancestry| 1,795 individuals | PGP000066 | Craig JE et al. Nat Genet (2020) | Reported Trait: Primary open-angle glaucoma (POAG) | — | AUROC: 0.71 [0.66, 0.77] | — | — | — | 
| PPM016165 | PSS010053| European Ancestry| 1,103 individuals | PGP000403 | Siggs OM et al. JAMA Ophthalmol (2022)|Ext. | Reported Trait: Visual field worsening | — | — | Hazard ratio (HR, top 5% vs bottom 95%): 1.5 [1.13, 1.97] Hazard ratio (HR, bottom 20% vs intermediate risk): 0.52 [0.28, 0.96] | — | — | 
| PPM020780 | PSS011408| European Ancestry| 903 individuals | PGP000588 | Marshall HN et al. Ophthalmol Glaucoma (2022)|Ext. | Reported Trait: Age at first trabeculectomy in individuals with primary open-angle glaucoma | β: -1.94 [-3.47, -0.41] | — | — | Sex, family history of glaucoma | — | 
| PPM020781 | PSS011408| European Ancestry| 903 individuals | PGP000588 | Marshall HN et al. Ophthalmol Glaucoma (2022)|Ext. | Reported Trait: Requirement for bilateral trabeculectomy in individuals with primary open-angle glaucoma | — | — | Odds ratio (OR, top vs bottom PRS decile): 1.41 [1.06, 1.91] | — | — | 
| PPM022190 | PSS011837| Multi-ancestry (including European)| 455 individuals | PGP000688 | Saks DG et al. Acta Ophthalmol (2023)|Ext. | Reported Trait: Vascular wedge presence in individuals with glaucoma | — | — | p: 0.007 | Age, sex, optic disc haemorrhage | — | 
| PPM022191 | PSS011837| Multi-ancestry (including European)| 455 individuals | PGP000688 | Saks DG et al. Acta Ophthalmol (2023)|Ext. | Reported Trait: Retinal nerve fibre layer wedge presence in individuals with glaucoma | — | — | p: 0.07 | Age, sex, optic disc haemorrhage | — | 
| PGS Sample Set ID (PSS) | Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| PSS010053 | — | — | 1,103 individuals | — | European | — | PROGRESSA | Ancestrally matched normative population cohort (n = 17 642) was used for PRS reference | 
| PSS000245 | — | — | [, 
 43.0 % Male samples | Mean = 64.02 years Sd = 8.24 years | European | — | BMES | — | 
| PSS000246 | MYOC p.Gln368Ter (rs74315329) carriers using imputation. Glaucoma cases were defined as those who (i) had an ICD-10 diagnosis of ‘primary open angle glaucoma’, ‘other glaucoma’ or ‘glaucoma, unspecified’; (ii) responded ‘glaucoma’ to the question ‘Has a doctor told you that you have any of the following problems with your eyes?’; or (iii) responded ‘glaucoma’ to the question ‘In the touch screen you selected that you have been told by a doctor that you have other serious illnesses or disabilities, could you now tell me what they are? (non-cancer illness). | — | [ 
 | — | European | — | UKB | — | 
| PSS000247 | ICD-10 defined Primary open-angle glaucoma (POAG) | — | [ 
 | — | European | — | UKB | — | 
| PSS000248 | Glaucoma cases were defined as those who (i) had an ICD-10 diagnosis of ‘primary open angle glaucoma’, ‘other glaucoma’ or ‘glaucoma, unspecified’; (ii) responded ‘glaucoma’ to the question ‘Has a doctor told you that you have any of the following problems with your eyes?’; or (iii) responded ‘glaucoma’ to the question ‘In the touch screen you selected that you have been told by a doctor that you have other serious illnesses or disabilities, could you now tell me what they are? (non-cancer illness). | — | [ 
 | — | European | — | UKB | — | 
| PSS000249 | Glaucoma cases were defined as those who (i) had an ICD-10 diagnosis of ‘primary open angle glaucoma’, ‘other glaucoma’ or ‘glaucoma, unspecified’; (ii) responded ‘glaucoma’ to the question ‘Has a doctor told you that you have any of the following problems with your eyes?’; or (iii) responded ‘glaucoma’ to the question ‘In the touch screen you selected that you have been told by a doctor that you have other serious illnesses or disabilities, could you now tell me what they are? (non-cancer illness). | — | [ 
 | — | South Asian | — | UKB | — | 
| PSS011837 | — | — | 429 individuals | — | European | — | PROGRESSA | — | 
| PSS011837 | — | — | 5 individuals | — | Asian unspecified | — | PROGRESSA | — | 
| PSS011837 | — | — | 1 individuals | — | Greater Middle Eastern (Middle Eastern, North African or Persian) | — | PROGRESSA | — | 
| PSS011837 | — | — | 1 individuals | — | Hispanic or Latin American | — | PROGRESSA | — | 
| PSS011837 | — | — | 19 individuals | — | Not reported | — | PROGRESSA | — | 
| PSS011408 | — | — | 903 individuals, 42.7 % Male samples | — | European | — | ANZRAG | — |